- $2.59m
- $2.96m
- $6.56m
- 56
- 74
- 11
- 44
Annual income statement for Encision, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.54 | 7.67 | 7.35 | 6.59 | 6.56 |
| Cost of Revenue | |||||
| Gross Profit | 3.91 | 3.79 | 4.03 | 3.14 | 3.51 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 7 | 7.73 | 7.65 | 7.23 | 6.73 |
| Operating Profit | 0.537 | -0.062 | -0.303 | -0.641 | -0.172 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.585 | -0.066 | -0.324 | -0.692 | -0.22 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.585 | -0.066 | -0.324 | -0.692 | -0.22 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.585 | -0.066 | -0.324 | -0.692 | -0.22 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.585 | -0.066 | -0.324 | -0.692 | -0.22 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.051 | -0.028 | -0.059 | -0.019 |